Your browser doesn't support javascript.
loading
Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in Vietnam.
Huyen, Dang Thi Thanh; Mach, Ondrej; Thanh Trung, Nguyen; Thai, Pham Quang; Thang, Ho Vinh; Weldon, William C; Oberste, M Steven; Jeyaseelan, Visalakshi; Sutter, Roland W; Anh, Dang Duc.
Afiliación
  • Huyen DTT; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Thanh Trung N; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Thai PQ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Thang HV; Pasteur Institute, Ho Chi Minh City, Vietnam.
  • Weldon WC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Jeyaseelan V; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Sutter RW; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Anh DD; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
J Infect Dis ; 220(3): 386-391, 2019 07 02.
Article en En | MEDLINE | ID: mdl-30869149
ABSTRACT

BACKGROUND:

Due to global shortage of inactivated poliovirus vaccine and withdrawal of oral vaccine containing poliovirus type 2 (PV2), a PV2-containing vaccine was not used in Vietnam May 2016 to October 2018. We assessed the population immunity gap to PV2.

METHODS:

A cross-sectional survey in children aged 1-18 months was carried out in January 2018. One blood sample per child was analyzed for presence of poliovirus neutralizing antibodies. In children with detectable anti-PV2 antibodies, a second sample was analyzed 4 months later to distinguish between passive (maternally derived) and active (induced by secondary transmission or vaccination) immunity.

RESULTS:

Sera were obtained from 1106/1110 children. Seroprevalence of PV2 antibodies was 87/368 (23.6%) at age 1-7 months, 27/471 (5.7%) at 8-15 months, and 19/267 (7.1%) at 16-18 months. Seroprevalence declined with age in the 1-7 months group; in the 8-18 months group there was no significant change with age. Four months later, 11/87 (14%), 9/27 (32%), and 12/19 (37%) remained seropositive in 1-7, 8-15, and 16-18 months age groups, respectively.

CONCLUSIONS:

We found declining immunity to PV2, suggesting Vietnam is at risk for an outbreak of type 2 vaccine-derived poliovirus following virus importation or new emergence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna Antipolio de Virus Inactivados / Vacuna Antipolio Oral / Poliovirus Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: Vietnam

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna Antipolio de Virus Inactivados / Vacuna Antipolio Oral / Poliovirus Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: Vietnam